Cargando…

The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: basing on competing risk model

BACKGROUND: The number of young patients with hepatocellular carcinoma (HCC) is increasing, but whether patients of different ages have a survival advantage is unclear. This study was conducted to investigate whether age differences in the Barcelona Clinic Liver Cancer (BCLC) classification system c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Huiwen, Wang, Xinhui, Liu, Xiaoli, Wang, Peng, Yu, Lihua, Zhou, Dongdong, Yang, Zhiyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855543/ https://www.ncbi.nlm.nih.gov/pubmed/35180841 http://dx.doi.org/10.1186/s12885-022-09293-x

Ejemplares similares

Impact of gender as a prognostic factor in HBV-related Hepatocellular Carcinoma: the survival strength of female patients in BCLC stage 0-B
por: Yu, Lihua, et al.
Publicado: (2019)

Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification
por: Kamiyama, Toshiya, et al.
Publicado: (2017)

Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia
por: Wang, Xinhui, et al.
Publicado: (2021)

Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage
por: Kikuchi, Luciana, et al.
Publicado: (2017)

The future of minimally invasive liver resection for hepatocellular carcinoma BCLC stage 0–A
por: Lippert, Trenton, et al.
Publicado: (2023)

Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2023)

An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma
por: He, Cheng, et al.
Publicado: (2022)

Efficacy and safety of transarterial chemoembolization combined with lenvatinib and camrelizumab in patients with BCLC-defined stage C hepatocellular carcinoma
por: Wu, Juan, et al.
Publicado: (2023)

Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival
por: Jin, Chen, et al.
Publicado: (2017)

Dynamic Nomogram for Predicting Macrovascular Invasion of Patients with Unresectable Hepatocellular Carcinoma after Transarterial Chemoembolization
por: Yan, Huiwen, et al.
Publicado: (2022)

Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients
por: Zhaohui, Zhang, et al.
Publicado: (2019)

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage
por: Ninomiya, Masashi, et al.
Publicado: (2023)

The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A
por: Zuo, Duo, et al.
Publicado: (2021)

A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy
por: Zhou, Dongdong, et al.
Publicado: (2021)

Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System
por: Wee, Ian J Y, et al.
Publicado: (2022)

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
por: Kim, Jun Young, et al.
Publicado: (2016)

Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
por: Liu, Kai-Cai, et al.
Publicado: (2020)

Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy
por: Huang, Pao-Yuan, et al.
Publicado: (2019)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
por: Yang, Shih-Yu, et al.
Publicado: (2021)

The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
por: Liu, Shun, et al.
Publicado: (2021)

Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
por: Zhong, Jian-Hong, et al.
Publicado: (2013)

A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma
por: Lin, Huapeng, et al.
Publicado: (2021)

TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma
por: Lima, Henrique A., et al.
Publicado: (2022)

A Nomogram Predicting Microvascular Invasion Risk in BCLC 0/A Hepatocellular Carcinoma after Curative Resection
por: Gao, Shuai-Xiang, et al.
Publicado: (2019)

Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B
por: Huang, Cheng, et al.
Publicado: (2017)

Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System
por: Kikuchi, Luciana, et al.
Publicado: (2016)

Correction: Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
por: Zhong, Jian-Hong, et al.
Publicado: (2014)

Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular Carcinoma
por: Kawamura, Yusuke, et al.
Publicado: (2023)

Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C)
por: Goswami, Pulak, et al.
Publicado: (2022)

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022)

Transcatheter arterial chemoembolisation (TACE) plus S-1 for the treatment of BCLC stage B hepatocellular carcinoma refractory to TACE
por: Huang, Wu-Kui, et al.
Publicado: (2017)

A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma
por: Mei, Jie, et al.
Publicado: (2019)

Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
por: Chen, Shiguang, et al.
Publicado: (2018)

Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy
por: Saeki, Issei, et al.
Publicado: (2023)

Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice
por: Lee, I-Cheng, et al.
Publicado: (2015)

Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B
por: Cho, Yuri, et al.
Publicado: (2016)

Establishment of Nomogram Model for Minimally Invasive Treatment of Small Hepatocellular Carcinoma Based on CD8(+)T Cell Counts
por: Pu, Qing, et al.
Publicado: (2022)

A Nomogram Prognostic Model for Advanced Hepatocellular Carcinoma Based on the Interaction Between CD8(+)T Cell Counts and Age
por: Wu, Yuan, et al.
Publicado: (2023)

Use of a Novel Thyroid-Stimulating Hormone Model for Predicting the Progression of Hepatocellular Carcinoma
por: Yu, Lihua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pu5a1s6obta1e661klvlancp0m